Saltagen Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Oncoustics develops ultrasound-based artificial intelligence and machine learning solutions for cancer detection and liver disease characterization, serving clinical researchers and healthcare providers.
AI & Machine LearningDigital HealthHealthtechMedical DevicesToronto, CA
Ahmed El Kaffas(Founder)Beth Rogozinski(CEO)in
Co-investorsCreative VenturesPallasite VenturesSony Ventures CorporationUCeed Funds
CybersecurityData & InfrastructureFintechChicago, US
Piers Nash(Executive Officer, Director)in
Co-investorsScaleGood Fund LP (powered by TELUS)Techstars
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Oncoustics AI
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.